ethnopharmacolog
relev
qing
dai
famou
tradit
chines
medicin
tcm
prepar
tradit
ferment
process
aerial
part
strobilanth
cusia
current
tcm
could
treat
variou
clinic
inflammatori
diseas
ulcer
coliti
psoriasi
howev
bioactiv
compon
qing
dai
unknown
clearli
aim
studi
isol
identifi
compon
qing
dai
materi
method
silica
gel
size
exclus
resin
use
column
chromatographi
isol
pure
compound
structur
isol
elucid
nmr
ms
uv
ir
spectra
optic
rotat
protein
gene
express
also
evalu
cell
model
luciferas
report
assay
respect
result
two
indol
alkaloid
includ
one
new
indigodol
cephalandol
b
isol
qing
dai
indigodol
could
inhibit
protein
product
polar
ec
polar
ec
without
cytotox
toward
cell
cephalandol
b
inhibit
protein
secret
nevertheless
isol
notabl
inhibit
gene
express
especi
cephalandol
b
dosedepend
manner
jukat
cell
luciferas
report
conclus
indol
alkaloid
indigodol
c
tryptanthrin
indirubin
could
contribut
antiil
properti
qing
dai
possibl
biogenet
mechan
abovement
indol
also
specul
investig
promis
lead
drug
develop
qing
dai
famou
tradit
chines
medicin
tcm
pale
blue
grayishblu
dri
powder
prepar
tradit
ferment
process
lee
et
al
lin
pan
et
al
current
tcm
could
treat
variou
clinic
inflammatori
diseas
ulcer
coliti
psoriasi
naganuma
sugimoto
et
al
aerial
part
strobilanth
cusia
nee
kuntz
acanthacea
record
taiwan
herbal
pharmacopeia
one
candid
materi
use
manufactur
qing
dai
lee
et
al
lin
crude
extract
pure
phytochem
cusia
leav
dachingyeh
nanbanlanyeh
root
nabanlangen
show
mani
pharmacolog
properti
includ
antivir
antiherp
simplex
viru
antiinfluenza
viru
antisever
acut
respiratori
syndrom
sar
antifung
antiinflammatori
antinocicept
antipyret
effect
feng
et
al
http
receiv
septemb
receiv
revis
form
march
accept
march
gu
et
al
ho
et
al
honda
tabata
tanaka
et
al
zhou
et
al
date
mani
secondari
metabolit
alkaloid
terpenoid
flavonoid
sterol
lignan
phenylethanoid
isocoumarin
isol
speci
feng
et
al
gu
et
al
honda
tabata
tanaka
et
al
zhou
et
al
howev
interleukin
inhibit
cusia
process
drug
qing
dai
known
qing
dai
could
provid
highli
effect
approach
psoriasi
topic
use
inflammatori
bowel
diseas
ibd
oral
use
modern
clinic
therapi
lee
et
al
sugimoto
et
al
addit
qing
dai
ointment
could
significantli
revers
gene
express
psoriat
skin
lesion
previou
studi
cheng
et
al
therefor
qing
dai
compon
interest
us
tcm
need
clarifi
activ
phytochem
clinic
applic
previou
investig
indic
indol
alkaloid
could
contribut
properti
qing
dai
prepar
aerial
part
cusia
lee
et
al
continu
studi
bioactiv
constitu
qing
dai
result
isol
two
compound
besid
inhibitori
effect
possibl
biogenet
pathway
activ
compon
also
discuss
within
nmr
spectra
taken
bruker
avanc
iii
mhz
chemic
shift
valu
report
ppm
cdcl
use
intern
standard
coupl
constant
j
hz
lowand
highresolut
esim
eim
measur
bruker
dalton
esquir
hct
ultra
high
capac
trap
mass
spectromet
orbitrap
mass
spectromet
ltq
orbitrap
xl
q
exact
plu
thermo
fisher
scientif
respect
optic
rotat
uv
ir
spectra
measur
polarimet
cell
length
mm
perkinelm
shimadzu
model
ir
fouriertransform
infrar
spectrophotomet
respect
tlc
perform
kieselgel
f
mm
merck
f
mm
merck
coat
plate
spot
recogn
ultraviolet
light
nm
stain
spray
h
meoh
heat
hot
plate
silica
gel
silicycl
mesh
merck
tosoh
japan
use
column
chromatographi
aerial
part
strobilanth
cusia
collect
putian
citi
fujian
provinc
china
process
tcm
name
qing
dai
local
gmp
pharmaceut
factori
april
aforement
tcm
powder
import
analyz
lot
sheng
chang
pharmaceut
co
ltd
zhongli
district
taoyuan
citi
taiwan
offer
studi
march
voucher
specimen
also
store
cmrdc
cmuh
taiwan
lee
et
al
qing
dai
dri
powder
kg
extract
meoh
l
room
temperatur
obtain
crude
extract
g
separ
etoacsolubl
fraction
aqueou
phase
etoac
h
vv
respect
former
one
partit
nhexan
meoh
aq
vv
give
nhexan
inh
g
meoh
aq
inea
g
solubl
crude
fraction
individu
fraction
inea
fraction
conduct
open
column
chromatographi
silica
gel
column
cm
diamet
length
use
gradient
nhexaneetoacmeoh
give
eight
subfract
ineaaineah
subfract
ineaf
g
subject
silica
gel
column
cm
nhexanech
cl
etoac
afford
seven
subfract
subfract
g
separ
silica
gel
chromatographi
column
cm
nhexaneetoac
nine
fraction
mg
purifi
column
cm
meohh
obtain
six
subfract
subfract
mg
subject
gel
chromatographi
column
cm
meohh
obtain
four
subfract
mg
purifi
silica
gel
chromatographi
column
cm
ch
cl
column
cm
nhexaneetoac
give
compound
mg
subfract
mg
separ
gel
chromatographi
column
cm
ch
cl
meoh
subfract
mg
isol
silica
gel
chromatographi
column
cm
nhexaneetoac
give
compound
mg
shimadzu
kyoto
japan
equip
degass
binari
pump
dad
detector
liquid
handler
cl
lee
et
al
journal
ethnopharmacolog
autosampl
appli
analyz
chemic
profil
qing
dai
mobil
phase
consist
water
contain
formic
acid
eluent
acetonitril
eluent
b
gradient
program
use
follow
b
min
min
isocrat
elut
min
min
isocrat
elut
min
hplc
column
mm
id
perform
analysi
run
equilibr
time
min
allow
flow
rate
mlmin
inject
volum
pure
compound
crude
extract
concentr
mgml
respect
uvvi
spectra
record
rang
nm
cell
isol
spleen
peripher
lymph
node
harvest
mice
via
mous
cell
isol
kit
stemcel
technolog
inc
vancouv
canada
accord
manufactur
protocol
previous
describ
benshaanan
et
al
kit
design
isol
cell
singlecel
suspens
splenocyt
lymphocyt
neg
select
unwant
cell
target
remov
biotinyl
antibodi
direct
nont
cell
streptavidinco
magnet
particl
desir
cell
isol
cellswel
cell
cultur
well
plate
coat
ab
day
follow
polar
condit
ab
biolegend
ngml
perotech
ngml
perotech
ngml
perotech
ngml
r
usa
ab
biolegend
ab
biolegend
cultur
medium
use
imdm
gibco
supplement
mm
sodium
pyruv
gibco
mm
nonessenti
amino
acid
gibco
iuml
penicillin
streptomycin
gibco
heatinactiv
fb
hyclon
harri
et
al
yen
et
al
evalu
effect
polar
cotreat
experi
cell
cultur
without
indic
compound
medium
polar
five
day
investig
level
product
polar
posttreat
experi
polar
cell
treat
without
indic
compound
h
lee
et
al
incub
cell
restimul
h
presenc
pma
ngml
ionomycin
ngml
golgistop
bd
bioscienc
secret
cell
stain
ab
bd
bioscienc
ab
biolegend
analyz
bd
facsvers
flow
cytomet
lee
et
al
result
promoterluciferas
gene
clone
construct
describ
previous
lee
et
al
jurkat
cell
transfect
promoterluciferas
gene
construct
control
vector
electropor
accord
manufactur
protocol
neon
transfect
system
invitrogen
stabl
express
luciferas
report
clone
jurkat
cell
select
gibco
neomycin
resist
luciferas
report
stabli
transfect
cell
cell
seed
densiti
cellswel
plate
follow
treatment
pma
ngml
ionomycin
ngml
indic
compound
h
assay
medium
renew
ad
volum
reagent
equal
volum
cultur
medium
well
min
activ
luciferas
transfect
cell
measur
biotek
synergi
micropl
reader
meoh
extract
qing
dai
powder
partit
etoacand
h
osolubl
extract
former
one
separ
nhexaneand
meohsolubl
fraction
chromatograph
fraction
activ
meohsolubl
one
afford
new
indigodol
known
cephalandol
b
nmr
spectra
support
inform
wu
et
al
see
fig
molecular
formula
deduc
c
h
n
due
appear
mna
ion
mz
hresim
ir
absorpt
cm
support
presenc
nh
carbonyl
group
respect
ir
absorpt
cm
indic
aromat
system
uv
spectra
show
absorpt
maxima
nm
nmr
spectra
tabl
twentyeight
carbon
signal
observ
agre
two
methyl
one
methylen
thirteen
methin
twelv
quaternari
carbon
among
twelv
quaternari
carbon
three
identifi
carbonyl
carbon
basi
chemic
shift
nmr
hsqc
cosi
data
also
indic
presenc
three
set
odisubstitut
benzen
ring
one
h
c
primari
mous
lymphocyt
polar
cell
investig
effect
two
indol
alkaloid
polar
cotreat
experi
secret
polar
posttreat
experi
fig
b
compound
cocultur
lymphocyt
skew
medium
five
day
evalu
effect
isol
polar
cotreat
experi
intracellular
stain
flow
cytometr
analysi
fig
show
reduc
polar
secret
cell
ec
valu
without
signific
cytotox
cell
fig
b
howev
compound
cotreat
significantli
inhibit
polar
dosedepend
manner
fig
b
fig
fig
although
seem
compound
could
inhibit
protein
product
concentr
dosedepend
manner
howev
dosedepend
inhibitori
effect
seen
concentr
moreov
investig
level
product
cell
ad
compound
h
polar
posttreat
experi
fig
compound
could
significantli
inhibit
product
ec
valu
without
cytotox
cell
fig
howev
cotreat
experi
cell
cultur
five
day
without
compound
skew
medium
cell
polar
five
day
cell
viabil
measur
stain
propidium
iodid
secret
cell
stain
ab
ab
analyz
flow
cytometri
b
posttreat
experi
polar
cell
treat
without
compound
h
incub
cell
restimul
pma
ionomycin
h
cell
viabil
measur
stain
propidium
iodid
c
secret
cell
stain
ab
ab
analyz
flow
cytometri
data
shown
repres
three
independ
experi
statist
test
perform
student
ttest
twotail
signific
level
p
p
compar
dmso
group
decreas
protein
product
compound
posttreat
experi
fig
might
due
cytotox
cell
concentr
fig
besid
mention
luciferas
report
assay
compound
could
notabl
inhibit
gene
express
jukat
cell
immort
lymphocyt
transfect
luciferas
report
fig
previou
studi
indol
alkaloid
includ
indigodol
indigodol
c
tryptanthrin
indirubin
also
suggest
contributor
qing
dai
lee
et
al
activ
compon
appli
chemic
profil
analys
use
hplcpda
chromatogram
shown
fig
hplc
chemic
analysi
tcm
methanol
extract
indic
activ
compound
retent
time
min
tabl
cotreat
experi
cell
cultur
five
day
without
compound
skew
medium
cell
polar
five
day
cell
viabil
measur
stain
propidium
iodid
secret
cell
stain
ab
ab
analyz
flow
cytometri
b
posttreat
experi
polar
cell
treat
without
compound
h
incub
cell
restimul
pma
ionomycin
h
cell
viabil
measur
stain
propidium
iodid
c
secret
cell
stain
ab
ab
analyz
flow
cytometri
data
shown
repres
three
independ
experi
statist
test
perform
student
ttest
twotail
signific
level
p
p
p
compar
dmso
group
fig
compound
inhibit
gene
express
luciferas
report
assay
cell
stimul
pma
ionomycin
cotreat
dmso
indic
compound
h
activ
luciferas
transfect
cell
measur
micropl
reader
vector
control
vector
transfect
cell
il
promoterluciferas
gene
transfect
cell
p
pma
ionomycin
data
shown
repres
three
independ
experi
statist
test
perform
student
ttest
twotail
signific
level
p
p
p
compar
dmso
group
qing
dai
manufactur
tradit
process
indigo
plant
cusia
fresh
botan
aerial
portion
contain
leav
stem
immers
water
rot
enzym
microorgan
tissu
residu
taken
lime
caco
ad
mixtur
constantli
stir
make
oxygen
air
take
part
consequ
lot
foam
liquid
surfac
gener
collect
dri
prepar
pale
blue
grayishblu
powder
use
tcm
name
qing
dai
lee
et
al
lin
pan
et
al
possibl
describ
biosynthet
origin
indol
alkaloid
qing
dai
basi
three
major
factor
precursor
indol
compon
cusia
oxygen
air
alkali
condit
propos
mechan
fig
indol
oxid
indolon
cytochrom
cyt
monooxygenas
oxid
acetylcoa
could
offer
ethyl
group
nadph
nicotinamid
adenin
dinucleotid
phosphat
give
hydrogen
reduct
reaction
cl
lee
et
al
journal
ethnopharmacolog
plausibl
biogenet
mechan
activ
indigodol
c
shown
fig
respect
addit
indirubin
tryptanthrin
indigodol
b
tryptanthrin
deriv
without
properti
previou
investig
shown
fig
qing
dai
process
drug
indigo
plant
use
modern
clinic
therapi
mani
inflamm
diseas
activ
compon
report
rare
believ
worthi
investig
studi
two
indol
alkaloid
includ
new
indigodol
obtain
qing
dai
isol
show
inhibit
gene
express
especi
also
show
dosedepend
inhibit
protein
product
besid
indol
alkaloid
indigodol
indigodol
c
tryptanthrin
indirubin
could
contribut
properti
qing
dai
well
possibl
biogenet
mechan
abovement
indol
also
specul
us
could
provid
valuabl
inform
medicin
chemist
make
activ
qing
dai
indol
analogu
structureact
relationship
mechan
action
need
evalu
clearli
clarifi
clinic
applic
conceiv
design
experi
cll
hri
perform
experi
cll
cmw
yc
ylc
cjc
analyz
data
cll
yhk
hri
cjc
wrote
paper
cll
yhk
hri
yc
author
declar
conflict
interest
